Database Retrieval for the Comprehensive Shoulder
Condition(s) studied
Investigational drug(s) / intervention(s)
Biomet Comprehensive Shoulder System: Total shoulder system designed to provide intraoperative flexibility for surgeons with unmatched humeral stem options, and infinite humeral head offset possibilities while meeting the growing demand for ease of glenoid preparation through a streamlined, low-profile, cannulated instrument platform
Study summary
This study is a retrieval of database information regarding survivorship of the Comprehensive Shoulder System family of products. The primary objective of the retrieval is to collect data that will contribute to the post market surveillance requirements for this product and will provide feedback to design engineers, support marketing efforts and publications, and answer potential questions form reimbursement agencies.
Eligibility
Primary outcome measure(s)
- Implant survivorship is assessed counting the number of implant revisions — 10 years
Implant survivorship will be documented by assessing the number of implant revisions occurring throughout the course of the study.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Acromion LLC | Towson | Maryland |
More Zimmer Biomet trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03409718 on ClinicalTrials.gov ↗ ← All trials in the USA